Price, M. Z., & Price, R. L. (2023). Authors’ Reply to Pande et al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'. CNS Drugs, 37, 939-940. https://doi.org/10.1007/s40263-023-01035-2
Chicago-Zitierstil (17. Ausg.)Price, Maxwell Z., und Richard L. Price. "Authors’ Reply to Pande Et Al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'." CNS Drugs 37 (2023): 939-940. https://doi.org/10.1007/s40263-023-01035-2.
MLA-Zitierstil (9. Ausg.)Price, Maxwell Z., und Richard L. Price. "Authors’ Reply to Pande Et Al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'." CNS Drugs, vol. 37, 2023, pp. 939-940, https://doi.org/10.1007/s40263-023-01035-2.